205 related articles for article (PubMed ID: 27067984)
1. Venous thromboembolism and occult cancer: impact on clinical practice.
Gheshmy A; Carrier M
Thromb Res; 2016 Apr; 140 Suppl 1():S8-11. PubMed ID: 27067984
[TBL] [Abstract][Full Text] [Related]
2. Occult cancer and thromboembolism: current epidemiology and its practical implications.
Chao CH; Wang HY; Kao CH
Pol Arch Intern Med; 2018 Sep; 128(9):539-544. PubMed ID: 30057385
[TBL] [Abstract][Full Text] [Related]
3. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.
Robin P; Otten HM; Delluc A; van Es N; Carrier M; Salaün PY; Le Gal G
Thromb Res; 2018 Nov; 171():92-96. PubMed ID: 30268858
[TBL] [Abstract][Full Text] [Related]
4. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
[TBL] [Abstract][Full Text] [Related]
5. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
6. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Le Moigne E; Planquette B; Prévot-Bitot N; Roy PM; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
Thromb Res; 2017 Jul; 155():6-9. PubMed ID: 28460260
[No Abstract] [Full Text] [Related]
7. Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
Robin P; Carrier M
Thromb Res; 2018 Apr; 164 Suppl 1():S7-S11. PubMed ID: 29703487
[TBL] [Abstract][Full Text] [Related]
8. Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
Carrier M; Lazo-Langner A; Shivakumar S; Tagalakis V; Zarychanski R; Solymoss S; Routhier N; Douketis J; Danovitch K; Lee AY; Le Gal G; Wells PS; Corsi DJ; Ramsay T; Coyle D; Chagnon I; Kassam Z; Tao H; Rodger MA;
N Engl J Med; 2015 Aug; 373(8):697-704. PubMed ID: 26095467
[TBL] [Abstract][Full Text] [Related]
9. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
Robin P; Kumar S; Salaun PY; Le Roux PY; Couturaud F; Planquette B; Merah A; Roy PM; Thavorn K; Le Gal G
Thromb Res; 2018 Nov; 171():97-102. PubMed ID: 30268859
[TBL] [Abstract][Full Text] [Related]
10. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.
Ihaddadene R; Corsi DJ; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Le Gal G; Carrier M
Blood; 2016 Apr; 127(16):2035-7. PubMed ID: 26817957
[TBL] [Abstract][Full Text] [Related]
11. Screening for Occult Cancer in Patients with Venous Thromboembolism.
D'Astous J; Carrier M
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32726911
[TBL] [Abstract][Full Text] [Related]
12. Occult cancer detection in patients with hemostatic disorder and venous thromboembolism.
Husseinzadeh H; Carrier M
Thromb Res; 2018 Mar; 163():242-245. PubMed ID: 28587726
[TBL] [Abstract][Full Text] [Related]
13. Performance of
Robin P; van Es N; Le Roux PY; Rondina M; Lecumberri R; Beckers M; Le Gal G; Salaun PY
Thromb Res; 2020 Oct; 194():153-157. PubMed ID: 32788108
[TBL] [Abstract][Full Text] [Related]
14. Extensive Computed Tomography versus Limited Screening for Detection of Occult Cancer in Unprovoked Venous Thromboembolism: A Multicenter, Controlled, Randomized Clinical Trial.
Prandoni P; Bernardi E; Valle FD; Visonà A; Tropeano PF; Bova C; Bucherini E; Islam MS; Piccioli A
Semin Thromb Hemost; 2016 Nov; 42(8):884-890. PubMed ID: 27764880
[TBL] [Abstract][Full Text] [Related]
15. Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future.
van Es N; Ay C; Jara-Palomares L
Hamostaseologie; 2020 Aug; 40(3):270-279. PubMed ID: 32726822
[TBL] [Abstract][Full Text] [Related]
16. Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Lacut K; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Le Gal G; Salaun PY
PLoS One; 2017; 12(6):e0178849. PubMed ID: 28570648
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study.
Chauchard M; Benali K; Papo T; Sacre K
Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083
[TBL] [Abstract][Full Text] [Related]
18. A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism.
Rosell A; Lundström S; Mackman N; Wallén H; Thålin C
J Thromb Thrombolysis; 2019 Jul; 48(1):111-118. PubMed ID: 30739306
[TBL] [Abstract][Full Text] [Related]
19. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of occult malignancy in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Tromeur C; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
Thromb Res; 2017 Nov; 159():48-51. PubMed ID: 28978463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
